The purpose of this study is to determine whether spironolactone are effective in the
reduction of albuminuria and diastolic disfunction of subjects with diabetic nephropathy.
Phase:
Phase 4
Details
Lead Sponsor:
Universidad de los Andes, Chile Universidad Los Andes, Chile